https://www.marketscreener.com/quote/stock/CHUGAI-PHARMACEUTICAL-CO--6491165/news/Chugai-Pharmaceutical-Results-from-Phase-III-SAkuraSky-Study-for-Chugai-s-Satralizumab-in-Neurom-29657411/?utm_source=telegram&utm_medium=social&utm_campaign=share